TL;DR
This systematic review evaluates the efficacy of preoperative antibiotic prophylaxis (ABP) in preventing infections following minimally invasive stone surgeries. The study concludes that while routine "blanket" antibiotics may not be necessary for all patients with sterile urine undergoing ureteroscopy, tailored and culture-based strategies are essential for high-risk patients to prevent serious complications like urosepsis.
What Problem Does This Paper Address?
Urolithiasis (kidney and ureteral stones) is a global health issue, with incidence rates climbing nearly 50% over the last three decades. While minimally invasive procedures like Ureteroscopy (URS), Retrograde Intrarenal Surgery (RIRS), and Percutaneous Nephrolithotomy (PNL) have revolutionized treatment, they aren't without risks. Postoperative infections—ranging from minor UTIs to life-threatening Systemic Inflammatory Response Syndrome (SIRS) and urosepsis—remain a significant concern.
The medical community faces a dilemma: over-prescribing antibiotics contributes to global antimicrobial resistance, but under-prescribing puts surgical patients at risk. This paper synthesizes recent literature to determine which patients actually benefit from ABP and which antibiotic regimens are most effective.
Methods
The authors conducted a systematic review following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. They searched PubMed and Scopus for studies published through February 2024 using keywords related to stone surgery and antibiotic prophylaxis.
- Inclusion Criteria: Studies had to involve at least 10 adult patients, describe the specific ABP used, and assess postoperative outcomes like sepsis, UTI, or SIRS.
- Study Selection: Out of 760 initial records, only 13 met the rigorous inclusion criteria (6 Randomized Controlled Trials and 7 prospective studies).
- Quality Control: The researchers used the Cochrane Risk of Bias tool to evaluate the quality of the evidence, categorizing studies by their risk of bias (low, moderate, or high).
Datasets
As a systematic review, the "dataset" consists of the aggregated results from the 13 included clinical studies. These studies spanned various geographical regions (including Italy, Taiwan, Germany, Japan, China, and Egypt) and involved patient cohorts ranging from approximately 80 to nearly 300 individuals per study.
Key Insights and Ideas
- The "Sterile Urine" Nuance: For patients with sterile preoperative urine undergoing URS or RIRS, the benefit of routine ABP is debatable. Some evidence suggests that omitting antibiotics in these low-risk cases does not significantly increase infection rates, helping to combat antibiotic resistance.
- Stone vs. Urine Cultures: A critical insight is that midstream urine cultures (PMUC) often fail to detect bacteria hiding within the stone itself or in the renal pelvis. These "hidden" reservoirs can trigger sepsis even when the initial urine test appears clear.
- Enhanced vs. Standard Prophylaxis: "Enhanced" protocols—which involve testing urine 10 days before surgery and tailoring antibiotics to specific sensitivities—showed significantly better outcomes (e.g., reducing UTI rates from 15.6% to 6.3%) compared to standard one-size-fits-all regimens.
- Fosfomycin's Potential: The review highlights Fosfomycin tromethamine as a promising, cost-effective oral alternative to traditional IV antibiotics, showing comparable efficacy in preventing post-RIRS infections.
Key Results
- PNL Risks: In Percutaneous Nephrolithotomy (PNL), preoperative positive cultures were strongly correlated with the development of SIRS ($p=0.001$).
- Bacteriuria Reduction: One RCT demonstrated that a single dose of Levofloxacin reduced postoperative bacteriuria from 12.5% to 1.8% ($p=0.026$).
- Sepsis Rates: The review noted that sepsis rates following RIRS can vary wildly (0.2% to 17.8%), but targeted ABP consistently mitigates the higher end of this risk spectrum.
- SIRS Incidence: In PNL studies, SIRS was observed in roughly 9.8% to 16.7% of patients, with higher frequencies in those with struvite (infection) stones or longer operative times.
Limitations and Future Work
The authors acknowledge several limitations:
- Heterogeneity: There is a lack of standardized definitions for "postoperative infection" and "SIRS" across the included studies, making direct quantitative comparisons difficult.
- Bias: Several studies were flagged for moderate to high risk of bias, which may affect the reliability of certain conclusions.
- Sample Sizes: Many of the included trials had relatively small cohorts.
Future Directions: The authors call for larger, multi-center RCTs to establish definitive protocols. They specifically suggest more research into "stone cultures" as a diagnostic tool and the development of personalized antibiotic strategies based on local resistance patterns rather than generic global guidelines.
Summary updated